Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

L. A. Farrer, L. A. Cupples, J. L. Haines, B. Hyman, W. A. Kukull, R. Mayeux, R. H. Myers, M. A. Pericak-Vance, N. Risch and C. M. van Duijn
Department of Neurology, Boston University School of Medicine, Mass 02118, USA. farrer@neugen.bu.edu

OBJECTIVE: To examine more closely the association between apolipoprotein E (APOE) genotype and Alzheimer disease (AD) by age and sex in populations of various ethnic and racial denominations. DATA SOURCES: Forty research teams contributed data on APOE genotype, sex, age at disease onset, and ethnic background for 5930 patients who met criteria for probable or definite AD and 8607 controls without dementia who were recruited from clinical, community, and brain bank sources. MAIN OUTCOME MEASURES: Odds ratios (ORs) and 95% confidence intervals (CIs) for AD, adjusted for age and study and stratified by major ethnic group (Caucasian, African American, Hispanic, and Japanese) and source, were computed for APOE genotypes epsilon2/epsilon2, epsilon2/epsilon3, epsilon2/epsilon4, epsilon3/epsilon4, and epsilon4/epsilon4 relative to the epsilon3/epsilon3 group. The influence of age and sex on the OR for each genotype was assessed using logistic regression procedures. RESULTS: Among Caucasian subjects from clinic- or autopsy-based studies, the risk of AD was significantly increased for people with genotypes epsilon2/epsilon4 (OR=2.6, 95% CI=1.6-4.0), epsilon3/epsilon4 (OR=3.2, 95% CI=2.8-3.8), and epsilon4/epsilon4 (OR=14.9, 95% CI= 10.8-20.6); whereas, the ORs were decreased for people with genotypes epsilon2/epsilon2 (OR=0.6, 95% CI=0.2-2.0) and epsilon2/epsilon3 (OR=0.6, 95% CI=0.5-0.8). The APOE epsilon4-AD association was weaker among African Americans and Hispanics, but there was significant heterogeneity in ORs among studies of African Americans (P<.03). The APOE epsilon4-AD association in Japanese subjects was stronger than in Caucasian subjects (epsilon3/epsilon4: OR=5.6, 95% CI=3.9-8.0; epsilon4/epsilon4: OR=33.1, 95% CI=13.6-80.5). The epsilon2/epsilon3 genotype appears equally protective across ethnic groups. We also found that among Caucasians, APOE genotype distributions are similar in groups of patients with AD whose diagnoses were determined clinically or by autopsy. In addition, we found that the APOE epsilon4 effect is evident at all ages between 40 and 90 years but diminishes after age 70 years and that the risk of AD associated with a given genotype varies with sex. CONCLUSIONS: The APOE epsilon4 allele represents a major risk factor for AD in all ethnic groups studied, across all ages between 40 and 90 years, and in both men and women. The association between APOE epsilon4 and AD in African Americans requires clarification, and the attenuated effect of APOE epsilon4 in Hispanics should be investigated further.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism
Lyly et al.
Hum Mol Genet 2008;17:1406-1417.
ABSTRACT | FULL TEXT  

Genetic tests for common diseases: new insights, old concerns
Melzer et al.
BMJ 2008;336:590-593.
FULL TEXT  

Lack of Association Between Apolipoprotein E Polymorphism and Vascular Dementia in Koreans
Ki Woong Kim et al.
J Geriatr Psychiatry Neurol 2008;21:12-17.
ABSTRACT  

Plasma amyloid {beta} protein is elevated in late-onset Alzheimer disease families
Ertekin-Taner et al.
Neurology 2008;70:596-606.
ABSTRACT | FULL TEXT  

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Whitwell et al.
Neurology 2008;70:512-520.
ABSTRACT | FULL TEXT  

From the Cover: Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism
Mosconi et al.
Proc. Natl. Acad. Sci. USA 2007;104:19067-19072.
ABSTRACT | FULL TEXT  

Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease
Hamshere et al.
Hum Mol Genet 2007;16:2703-2712.
ABSTRACT | FULL TEXT  

Apolipoprotein E {varepsilon}4 Genotype and Gender: Effects on Memory
Sundermann et al.
AJGP 2007;15:869-878.
ABSTRACT | FULL TEXT  

BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
Seabrook et al.
Mol. Interv. 2007;7:261-270.
ABSTRACT | FULL TEXT  

The Pathogenesis of Alzheimers Disease Is It a Lifelong "Calciumopathy"?
Stutzmann
Neuroscientist 2007;13:546-559.
ABSTRACT  

Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study
Reitz et al.
Neurology 2007;69:998-1005.
ABSTRACT | FULL TEXT  

Cognitive Domain Decline in Healthy Apolipoprotein E {varepsilon}4 Homozygotes Before the Diagnosis of Mild Cognitive Impairment
Caselli et al.
Arch Neurol 2007;64:1306-1311.
ABSTRACT | FULL TEXT  

No association of CSF biomarkers with APOE{varepsilon}4, plaque and tangle burden in definite Alzheimer's disease
Engelborghs et al.
Brain 2007;130:2320-2326.
ABSTRACT | FULL TEXT  

Dopamine Genes and Schizophrenia: Case Closed or Evidence Pending?
Talkowski et al.
Schizophr Bull 2007;33:1071-1081.
ABSTRACT | FULL TEXT  

Plasma Homocysteine Is Associated with the Risk of Mild Cognitive Impairment in an Elderly Korean Population
Kim et al.
J. Nutr. 2007;137:2093-2097.
ABSTRACT | FULL TEXT  

Differences in the Association Between Apolipoprotein E Genotype and Mortality Across Populations
Ewbank
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:899-907.
ABSTRACT | FULL TEXT  

Neuropsychological Measures in Normal Individuals That Predict Subsequent Cognitive Decline
Blacker et al.
Arch Neurol 2007;64:862-871.
ABSTRACT | FULL TEXT  

Invited Commentary: When Bad Genes Look Good--APOE*E4, Cognitive Decline, and Diagnostic Thresholds
Glymour
Am J Epidemiol 2007;165:1239-1246.
ABSTRACT | FULL TEXT  

Prevalence of dementia in Chamorros on Guam: Relationship to age, gender, education, and APOE
Galasko et al.
Neurology 2007;68:1772-1781.
ABSTRACT | FULL TEXT  

Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population 1
Masemola et al.
Scand J Public Health 2007;35:60-65.
ABSTRACT  

Ethnicity-specific Gene-Gene Interaction between IL-13 and IL-4R{alpha} among African Americans with Asthma
Battle et al.
Am. J. Respir. Crit. Care Med. 2007;175:881-887.
ABSTRACT | FULL TEXT  

How migraines impact cognitive function: Findings from the Baltimore ECA
Kalaydjian et al.
Neurology 2007;68:1417-1424.
ABSTRACT | FULL TEXT  

Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus
Graham et al.
Proc. Natl. Acad. Sci. USA 2007;104:6758-6763.
ABSTRACT | FULL TEXT  

Measuring the Risk of Alzheimer Disease
Rosenberg
Arch Neurol 2007;64:479-480.
FULL TEXT  

Cholesterol and Triglycerides Moderate the Effect of Apolipoprotein E on Memory Functioning in Older Adults
de Frias et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2007;62:P112-P118.
ABSTRACT | FULL TEXT  

Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain
Staessen et al.
Hypertension 2007;49:389-400.
FULL TEXT  

Linking Brain Imaging and Genomics in the Study of Alzheimer's Disease and Aging
REIMAN
Ann. N. Y. Acad. Sci. 2007;1097:94-113.
ABSTRACT | FULL TEXT  

Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia
Sundar et al.
Hum Mol Genet 2007;16:295-306.
ABSTRACT | FULL TEXT  

The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between {beta}-amyloid production and tau phosphorylation in Alzheimer disease
Kimura et al.
Hum Mol Genet 2007;16:15-23.
ABSTRACT | FULL TEXT  

The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer's Disease
Xu et al.
Diabetes 2007;56:211-216.
ABSTRACT | FULL TEXT  

Lower Prevalence of Epsilon 4 Allele of Apolipoprotein E Gene in Healthy, Longer-Lived Individuals of Hellenic Origin
Stakias et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2006;61:1228-1231.
ABSTRACT | FULL TEXT  

Human telomere biology: pitfalls of moving from the laboratory to epidemiology
Aviv et al.
Int J Epidemiol 2006;35:1424-1429.
ABSTRACT | FULL TEXT  

Primary prevention trials in Alzheimer disease.
Green and DeKosky
Neurology 2006;67:S2-S5.
ABSTRACT | FULL TEXT  

Prevention trials in Alzheimer disease: One step forward?
Touchon et al.
Neurology 2006;67:S21-S22.
ABSTRACT | FULL TEXT  

Activation of estrogen receptor {alpha} increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo
Wang et al.
Proc. Natl. Acad. Sci. USA 2006;103:16983-16988.
ABSTRACT | FULL TEXT  

100 Years and Counting: Prospects for Defeating Alzheimer's Disease
Roberson and Mucke
Science 2006;314:781-784.
ABSTRACT | FULL TEXT  

Ashkenazi Jews and Breast Cancer: The Consequences of Linking Ethnic Identity to Genetic Disease
Brandt-Rauf et al.
Am. J. Public Health 2006;96:1979-1988.
ABSTRACT | FULL TEXT  

Apolipoprotein E {varepsilon}4 and Age at Onset of Sporadic and Familial Alzheimer Disease in Caribbean Hispanics
Olarte et al.
Arch Neurol 2006;63:1586-1590.
ABSTRACT | FULL TEXT  

Regional brain atrophy in cognitively intact adults with a single APOE {varepsilon}4 allele.
Wishart et al.
Neurology 2006;67:1221-1224.
ABSTRACT | FULL TEXT  

Implications of Small Effect Sizes of Individual Genetic Variants on the Design and Interpretation of Genetic Association Studies of Complex Diseases
Ioannidis et al.
Am J Epidemiol 2006;164:609-614.
ABSTRACT | FULL TEXT  

Geographic Ancestry, Angiotensinogen Gene Polymorphism, and Cardiovascular Risk
Castellano
Hypertension 2006;48:562-563.
FULL TEXT  

Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration
Thakkinstian et al.
Hum Mol Genet 2006;15:2784-2790.
ABSTRACT | FULL TEXT  

Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury.
Isoniemi et al.
Neurology 2006;67:756-760.
ABSTRACT | FULL TEXT  

Genetics and Dementia Nosology
Blacker and Lovestone
J Geriatr Psychiatry Neurol 2006;19:186-191.
ABSTRACT  

"A Gene for. . .":The Nature of Gene Action in Psychiatric Disorders
Kendler
Focus 2006;4:391.
ABSTRACT | FULL TEXT  

Apolipoprotein E {varepsilon}4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study
Lehmann et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:902-908.
ABSTRACT | FULL TEXT  

When it runs in the family: putting susceptibility genes in perspective
Lock et al.
Public Understanding of Science 2006;15:277-300.
ABSTRACT  

Effect of apolipoprotein e on the cerebral load of latent herpes simplex virus type 1 DNA.
Burgos et al.
J. Virol. 2006;80:5383-5387.
ABSTRACT | FULL TEXT  

Commentary: Grading the credibility of molecular evidence for complex diseases
Ioannidis
Int J Epidemiol 2006;35:572-578.
FULL TEXT  

Structural and Functional Variations in Human Apolipoprotein E3 and E4
Chou et al.
J. Biol. Chem. 2006;281:13333-13344.
ABSTRACT | FULL TEXT  

Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus.
Xu et al.
J. Neurosci. 2006;26:4985-4994.
ABSTRACT | FULL TEXT  

Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
Esposito et al.
J. Neurosci. 2006;26:5167-5179.
ABSTRACT | FULL TEXT  

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers
Burwick et al.
Neurology 2006;66:1373-1383.
ABSTRACT | FULL TEXT  

Reduced functional brain activity response in cognitively intact apolipoprotein E {varepsilon}4 carriers
Lind et al.
Brain 2006;129:1240-1248.
ABSTRACT | FULL TEXT  

The distribution of apolipoprotein E alleles in Scottish perinatal deaths
Becher et al.
J. Med. Genet. 2006;43:414-418.
ABSTRACT | FULL TEXT  

Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease
Mahley et al.
Proc. Natl. Acad. Sci. USA 2006;103:5644-5651.
ABSTRACT | FULL TEXT  

Clinical trials in mild cognitive impairment: lessons for the future
Jelic et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:429-438.
ABSTRACT | FULL TEXT  

Race and ethnicity in the era of emerging pharmacogenomics.
Harty et al.
J Clin Pharmacol 2006;46:405-407.
ABSTRACT | FULL TEXT  

Association of apolipoprotein e genotype and Alzheimer disease in african americans.
Murrell et al.
Arch Neurol 2006;63:431-434.
ABSTRACT | FULL TEXT  

Combination of Clinical and Neuropsychologic Information as a Better Predictor of the Progression to Alzheimer Disease in Questionable Dementia Individuals
Lee et al.
AJGP 2006;14:130-138.
ABSTRACT | FULL TEXT  

Role of Genes and Environments for Explaining Alzheimer Disease
Gatz et al.
Arch Gen Psychiatry 2006;63:168-174.
ABSTRACT | FULL TEXT  

Cholesterol, APOE genotype, and Alzheimer disease: An epidemiologic study of Nigerian Yoruba
Hall et al.
Neurology 2006;66:223-227.
ABSTRACT | FULL TEXT  

Heart Disease and Dementia: A Population-based Study
Bursi et al.
Am J Epidemiol 2006;163:135-141.
ABSTRACT | FULL TEXT  

Polymorphisms in the PON gene cluster are associated with Alzheimer disease
Erlich et al.
Hum Mol Genet 2006;15:77-85.
ABSTRACT | FULL TEXT  

Apolipoprotein E Genotype and Age-Related Myelin Breakdown in Healthy Individuals: Implications for Cognitive Decline and Dementia
Bartzokis et al.
Arch Gen Psychiatry 2006;63:63-72.
ABSTRACT | FULL TEXT  

Apolipoprotein E Genotype Modifies the Phenotype of Alzheimer Disease
Schott et al.
Arch Neurol 2006;63:155-156.
FULL TEXT  

APOE alleles predict the rate of cognitive decline in Alzheimer disease: A nonlinear model
Martins et al.
Neurology 2005;65:1888-1893.
ABSTRACT | FULL TEXT  

Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity
Chang et al.
Proc. Natl. Acad. Sci. USA 2005;102:18694-18699.
ABSTRACT | FULL TEXT  

Apolipoprotein (apo) E4 enhances amyloid {beta} peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target
Ye et al.
Proc. Natl. Acad. Sci. USA 2005;102:18700-18705.
ABSTRACT | FULL TEXT  

Children of Alzheimer Patients: An Overview
Jarvik and Blazer
J Geriatr Psychiatry Neurol 2005;18:181-186.
 

Genetic Risk Assessment for Adult Children of People With Alzheimer's Disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) Study
Roberts et al.
J Geriatr Psychiatry Neurol 2005;18:250-255.
ABSTRACT  

Looking Forward in Geriatric Anxiety and Depression: Implications of Basic Science for the Future
Gershenfeld et al.
AJGP 2005;13:1027-1040.
ABSTRACT | FULL TEXT  

Genetic Heterogeneity in Association of the SUMO4 M55V Variant With Susceptibility to Type 1 Diabetes
Noso et al.
Diabetes 2005;54:3582-3586.
ABSTRACT | FULL TEXT  

Genetic susceptibility for Alzheimer's disease: Why did adult offspring seek testing?
Hurley et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2005;20:374-381.
ABSTRACT  

Modulation of Apolipoprotein E Structure by Domain Interaction: DIFFERENCES IN LIPID-BOUND AND LIPID-FREE FORMS
Hatters et al.
J. Biol. Chem. 2005;280:34288-34295.
ABSTRACT | FULL TEXT  

Shared genetic risk factors for obstructive sleep apnea and obesity
Patel
J. Appl. Physiol. 2005;99:1600-1606.
ABSTRACT | FULL TEXT  

Complexity of Work and Risk of Alzheimer's Disease: A Population-Based Study of Swedish Twins
Andel et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2005;60:P251-P258.
ABSTRACT | FULL TEXT  

Firing up the nature/nurture controversy: bioethics and genetic determinism
de Melo-Martin
J. Med. Ethics 2005;31:526-530.
ABSTRACT | FULL TEXT  

Genetic Influences on Health: Does Race Matter?
Bamshad
JAMA 2005;294:937-946.
ABSTRACT | FULL TEXT  

Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease
Lehmann et al.
Am J Epidemiol 2005;162:305-317.
ABSTRACT | FULL TEXT  

Subjective Memory Complaints With and Without Objective Memory Impairment: Relationship With Risk Factors for Dementia
Lautenschlager et al.
AJGP 2005;13:731-734.
ABSTRACT | FULL TEXT  

APOE, vascular pathology, and the AD brain
Yip et al.
Neurology 2005;65:259-265.
ABSTRACT | FULL TEXT  

Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?
Lambert et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:928-933.
ABSTRACT | FULL TEXT  

"A Gene for...": The Nature of Gene Action in Psychiatric Disorders
Kendler
Am. J. Psychiatry 2005;162:1243-1252.
ABSTRACT | FULL TEXT  

From The Cover: Correlations between apolipoprotein E {epsilon}4 gene dose and brain-imaging measurements of regional hypometabolism
Reiman et al.
Proc. Natl. Acad. Sci. USA 2005;102:8299-8302.
ABSTRACT | FULL TEXT  

Sex, Apolipoprotein E {varepsilon}4 Status, and Hippocampal Volume in Mild Cognitive Impairment
Fleisher et al.
Arch Neurol 2005;62:953-957.
ABSTRACT | FULL TEXT  

Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
Barnes et al.
Arch Gen Psychiatry 2005;62:685-691.
ABSTRACT | FULL TEXT  

Apolipoprotein E, B Vitamins, and Cognitive Function in Older Adults
Bunce et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2005;60:P41-P48.
ABSTRACT | FULL TEXT  

Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
Lane and Farlow
J. Lipid Res. 2005;46:949-968.
ABSTRACT | FULL TEXT  

Earlier Onset of Alzheimer Disease Symptoms in Latino Individuals Compared With Anglo Individuals
Clark et al.
Arch Neurol 2005;62:774-778.
ABSTRACT | FULL TEXT  

Variability of Familial Risk of Alzheimer Disease Across the Late Life Span
Silverman et al.
Arch Gen Psychiatry 2005;62:565-573.
ABSTRACT | FULL TEXT  

Family-Based Association between Alzheimer's Disease and Variants in UBQLN1
Bertram et al.
NEJM 2005;352:884-894.
ABSTRACT | FULL TEXT  

Cholesterol and apolipoprotein E in Alzheimer's disease
Reiss
AM J ALZHEIMERS DIS OTHER DEMEN 2005;20:91-96.
ABSTRACT  

Alzheimer's disease: genetic variables and risk
Secko
CMAJ 2005;172:627-627.
FULL TEXT  

Mutation Screening and Association Study of the Neprilysin Gene in Sporadic Alzheimer's Disease in Chinese Persons
Shi et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:301-306.
ABSTRACT | FULL TEXT  

Apolipoprotein {varepsilon}4 Allele and Problems With Orientation Are Associated With a Persistent Decline in Cognition in Community-Dwelling Elderly Persons
Wayne et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:375-379.
ABSTRACT | FULL TEXT